Educational Webinars

An Update on AMX0035 and Design of the Phase 3 PHOENIX Study


Please join Dr. Merit Cudkowicz, MD, MSc (Sean M. Healey & AMG Center for ALS at Mass General Hospital) and Dr. Sabrina Paganoni, MD, PhD (Sean M. Healey & AMG Center for ALS at Mass General Hospital) for a conversation about recent updates on AMX0035 (sodium phenylbutyrate/taurursodiol) and to review details of the Phase 3 PHOENIX Study (Study A35-004).